ITPB 1 vs 3 in VATS
Recruiting
N/A
Interventional Study
Musculoskeletal Diseases or Conditions
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the quality of recovery after video-assisted thoracoscopic surgery (VATS) by comparing the efficacy of a single-level intertransverse process block (ITPB) against a three-level ITPB, with particular attention to the quality of recovery measured by the QoR15 score at 24 hours post-surgery.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ASA I-III patients
* 18 to 80 years of age
* Patients with primary carcinoma lung scheduled for resection under VATS procedure
Exclusion Criteria:
* Patient refusal
* Local skin infection at the area of injection
* Coagulopathy
* History of allergy to local anaesthetics
Contacts